diff --git a/.gitignore b/.gitignore index 7475617..443ca22 100644 --- a/.gitignore +++ b/.gitignore @@ -10,6 +10,10 @@ __pycache__/ .ipynb_checkpoints/omim-checkpoint.ipynb .git.bfg-report/ *ignore/ +analyses/**/*.ipynb_checkpoints +analyses/**/*.tsv +analyses/**/*.csv +analyses/**/*.xls # Inputs mim2gene.txt diff --git a/analyses/morbidmap-data-analysis/Analyze_morbidmap - v1.ipynb b/analyses/morbidmap-data-analysis/Analyze_morbidmap - v1.ipynb new file mode 100644 index 0000000..682b0a6 --- /dev/null +++ b/analyses/morbidmap-data-analysis/Analyze_morbidmap - v1.ipynb @@ -0,0 +1,2835 @@ +{ + "cells": [ + { + "cell_type": "markdown", + "id": "4dd60ae9-4735-46ba-84e4-f0f86b1f1ca1", + "metadata": {}, + "source": [ + "## Analyze Morbidmap content - v1\n", + "\n", + "The goal of this notebook is to analyze the content of the files from OMIM called morbidmap and mimTitles in order to create a gold standard list of diseases that should be represented in Mondo with 'has material basis in germline mutation in' some GENE. The diseases in this list can be used for comparison of results through the various transformations that occur of the omim content to confirm the final representation is correct.\n", + "\n", + "To download these files, request an API key from OMIM (https://omim.org/contact#) and then create the files using `python -m omim2obo` based on the instructions in the [README](https://github.com/monarch-initiative/omim) in the omim repo.\n", + "\n", + "\n", + "For this analysis, the working assumption is that the gene associations to add into Mondo are:\n", + "- those that have a Phenotype Mapping key value of 3 and there is only one Phenotype to Gene Relationship for the given OMIM Phenotype MIM\n", + "\n", + "**OR**\n", + "\n", + "- there is a digenic association\n", + "\n", + "\n", + "See https://omim.org/help/faq#1_6 for more details on what the Phenotype mapping key values mean and additional formatting, [], {}, ?, found in phenotype labels. See https://omim.org/help/faq#1_3 for information on what the Prefix values in the file mimTitles means.\n", + "\n", + "\n", + "** **TODO** **: The working assumption needs to be confirmed \n", + "\n", + "The results of this analysis under the working assumptions above is at [OMIM Disease-Gene Issues](https://docs.google.com/document/d/1cLfBgPIZWiN5LX-E-xwSyBeFdT-vw0JuSfSM7HL3_hc/edit?usp=sharing)" + ] + }, + { + "cell_type": "markdown", + "id": "7298ca7b-deb9-4022-9bc0-604a0bfadf25", + "metadata": {}, + "source": [ + "### Imports" + ] + }, + { + "cell_type": "code", + "execution_count": 1, + "id": "1168a6f8-d07c-481f-a0f6-1a4963e72952", + "metadata": {}, + "outputs": [], + "source": [ + "# Imports\n", + "import pandas as pd\n", + "import re\n", + "\n", + "# Set the display option to show full column width\n", + "pd.set_option('display.max_colwidth', None)" + ] + }, + { + "cell_type": "markdown", + "id": "d08ea9fe-8682-4e00-a2d3-4ed7ee31fb7e", + "metadata": {}, + "source": [ + "### Read in data file" + ] + }, + { + "cell_type": "code", + "execution_count": 2, + "id": "b366fa9e-f128-4ab6-9217-e5c8f6c65a9b", + "metadata": {}, + "outputs": [ + { + "data": { + "text/html": [ + "
\n", + " | Phenotype | \n", + "Gene/Locus And Other Related Symbols | \n", + "MIM Number | \n", + "Cyto Location | \n", + "
---|---|---|---|---|
0 | \n", + "17,20-lyase deficiency, isolated, 202110 (3) | \n", + "CYP17A1, CYP17, P450C17 | \n", + "609300 | \n", + "10q24.32 | \n", + "
1 | \n", + "17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3) | \n", + "CYP17A1, CYP17, P450C17 | \n", + "609300 | \n", + "10q24.32 | \n", + "
2 | \n", + "2,4-dienoyl-CoA reductase deficiency, 616034 (3) | \n", + "NADK2, C5orf33, DECRD | \n", + "615787 | \n", + "5p13.2 | \n", + "
3 | \n", + "2-methylbutyrylglycinuria, 610006 (3) | \n", + "ACADSB, SBCAD | \n", + "600301 | \n", + "10q26.13 | \n", + "
4 | \n", + "3-M syndrome 1, 273750 (3) | \n", + "CUL7, 3M1 | \n", + "609577 | \n", + "6p21.1 | \n", + "
\n", + " | Phenotype | \n", + "Gene/Locus And Other Related Symbols | \n", + "MIM Number | \n", + "Cyto Location | \n", + "p_label | \n", + "p_mim | \n", + "p_mapping_key | \n", + "
---|---|---|---|---|---|---|---|
0 | \n", + "17,20-lyase deficiency, isolated, 202110 (3) | \n", + "CYP17A1, CYP17, P450C17 | \n", + "609300 | \n", + "10q24.32 | \n", + "17,20-lyase deficiency, isolated | \n", + "202110 | \n", + "3 | \n", + "
1 | \n", + "17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3) | \n", + "CYP17A1, CYP17, P450C17 | \n", + "609300 | \n", + "10q24.32 | \n", + "17-alpha-hydroxylase/17,20-lyase deficiency | \n", + "202110 | \n", + "3 | \n", + "
2 | \n", + "2,4-dienoyl-CoA reductase deficiency, 616034 (3) | \n", + "NADK2, C5orf33, DECRD | \n", + "615787 | \n", + "5p13.2 | \n", + "2,4-dienoyl-CoA reductase deficiency | \n", + "616034 | \n", + "3 | \n", + "
3 | \n", + "2-methylbutyrylglycinuria, 610006 (3) | \n", + "ACADSB, SBCAD | \n", + "600301 | \n", + "10q26.13 | \n", + "2-methylbutyrylglycinuria | \n", + "610006 | \n", + "3 | \n", + "
4 | \n", + "3-M syndrome 1, 273750 (3) | \n", + "CUL7, 3M1 | \n", + "609577 | \n", + "6p21.1 | \n", + "3-M syndrome 1 | \n", + "273750 | \n", + "3 | \n", + "
\n", + " | Phenotype | \n", + "Gene/Locus And Other Related Symbols | \n", + "MIM Number | \n", + "Cyto Location | \n", + "p_label | \n", + "p_mim | \n", + "p_mapping_key | \n", + "
---|---|---|---|---|---|---|---|
2 | \n", + "2,4-dienoyl-CoA reductase deficiency, 616034 (3) | \n", + "NADK2, C5orf33, DECRD | \n", + "615787 | \n", + "5p13.2 | \n", + "2,4-dienoyl-CoA reductase deficiency | \n", + "616034 | \n", + "3 | \n", + "
3 | \n", + "2-methylbutyrylglycinuria, 610006 (3) | \n", + "ACADSB, SBCAD | \n", + "600301 | \n", + "10q26.13 | \n", + "2-methylbutyrylglycinuria | \n", + "610006 | \n", + "3 | \n", + "
4 | \n", + "3-M syndrome 1, 273750 (3) | \n", + "CUL7, 3M1 | \n", + "609577 | \n", + "6p21.1 | \n", + "3-M syndrome 1 | \n", + "273750 | \n", + "3 | \n", + "
5 | \n", + "3-M syndrome 2, 612921 (3) | \n", + "OBSL1, KIAA0657, 3M2 | \n", + "610991 | \n", + "2q35 | \n", + "3-M syndrome 2 | \n", + "612921 | \n", + "3 | \n", + "
6 | \n", + "3-M syndrome 3, 614205 (3) | \n", + "CCDC8, 3M3 | \n", + "614145 | \n", + "19q13.32 | \n", + "3-M syndrome 3 | \n", + "614205 | \n", + "3 | \n", + "
\n", + " | Phenotype | \n", + "Gene/Locus And Other Related Symbols | \n", + "MIM Number | \n", + "Cyto Location | \n", + "p_label | \n", + "p_mim | \n", + "p_mapping_key | \n", + "
---|---|---|---|---|---|---|---|
6256 | \n", + "Prune belly syndrome, 100100 (3) | \n", + "CHRM3, PBS, EGBRS | \n", + "118494 | \n", + "1q43 | \n", + "Prune belly syndrome | \n", + "100100 | \n", + "3 | \n", + "
7305 | \n", + "Usher syndrome, type 1D, 601067 (3) | \n", + "CDH23, USH1D, DFNB12, PITA5 | \n", + "605516 | \n", + "10q22.1 | \n", + "Usher syndrome, type 1D | \n", + "601067 | \n", + "3 | \n", + "
7306 | \n", + "Usher syndrome, type 1D/F digenic, 601067 (3) | \n", + "CDH23, USH1D, DFNB12, PITA5 | \n", + "605516 | \n", + "10q22.1 | \n", + "Usher syndrome, type 1D/F digenic | \n", + "601067 | \n", + "3 | \n", + "
7307 | \n", + "Usher syndrome, type 1D/F digenic, 601067 (3) | \n", + "PCDH15, DFNB23, USH1F | \n", + "605514 | \n", + "10q21.1 | \n", + "Usher syndrome, type 1D/F digenic | \n", + "601067 | \n", + "3 | \n", + "
\n", + " | Phenotype | \n", + "Gene/Locus And Other Related Symbols | \n", + "MIM Number | \n", + "Cyto Location | \n", + "p_label | \n", + "p_mim | \n", + "p_mapping_key | \n", + "p_mim_count | \n", + "
---|---|---|---|---|---|---|---|---|
274 | \n", + "?Facioscapulohumeral muscular dystrophy 3, digenic, 619477 (3) | \n", + "LRIF1, RIF1, FSHD3 | \n", + "615354 | \n", + "1p13.3 | \n", + "?Facioscapulohumeral muscular dystrophy 3, digenic | \n", + "619477 | \n", + "3 | \n", + "1 | \n", + "
571 | \n", + "?Proteasome-associated autoinflammatory syndrome 3 and digenic forms, 617591 (3) | \n", + "PSMB4, PRAAS3 | \n", + "602177 | \n", + "1q21.3 | \n", + "?Proteasome-associated autoinflammatory syndrome 3 and digenic forms | \n", + "617591 | \n", + "3 | \n", + "1 | \n", + "
707 | \n", + "AMED syndrome, digenic, 619151 (3) | \n", + "ADH5, FDH, AMEDS, BMFS7 | \n", + "103710 | \n", + "4q23 | \n", + "AMED syndrome, digenic | \n", + "619151 | \n", + "3 | \n", + "1 | \n", + "
1115 | \n", + "Atrial standstill, digenic (GJA5/SCN5A), 108770 (3) | \n", + "GJA5, CX40, ATFB11 | \n", + "121013 | \n", + "1q21.2 | \n", + "Atrial standstill, digenic (GJA5/SCN5A) | \n", + "108770 | \n", + "3 | \n", + "1 | \n", + "
2772 | \n", + "Dyskeratosis congenita, digenic, 620040 (3) | \n", + "TYMS, TS, TMS, DKCD | \n", + "188350 | \n", + "18p11.32 | \n", + "Dyskeratosis congenita, digenic | \n", + "620040 | \n", + "3 | \n", + "1 | \n", + "
3068 | \n", + "Facioscapulohumeral muscular dystrophy 2, digenic, 158901 (3) | \n", + "SMCHD1, KIAA0650, BAMS | \n", + "614982 | \n", + "18p11.32 | \n", + "Facioscapulohumeral muscular dystrophy 2, digenic | \n", + "158901 | \n", + "3 | \n", + "1 | \n", + "
3069 | \n", + "Facioscapulohumeral muscular dystrophy 4, digenic, 619478 (3) | \n", + "DNMT3B, ICF1, FSHD4 | \n", + "602900 | \n", + "20q11.21 | \n", + "Facioscapulohumeral muscular dystrophy 4, digenic | \n", + "619478 | \n", + "3 | \n", + "1 | \n", + "
6246 | \n", + "Proteasome-associated autoinflammatory syndrome 1 and digenic forms, 256040 (3) | \n", + "PSMB8, LMP7, RING10, JMP, NKJO, ALDD, PRAAS1 | \n", + "177046 | \n", + "6p21.32 | \n", + "Proteasome-associated autoinflammatory syndrome 1 and digenic forms | \n", + "256040 | \n", + "3 | \n", + "1 | \n", + "
602 | \n", + "?Roifman-Chitayat syndrome, digenic, 613328 (3) | \n", + "KNSTRN, C15orf23, SKAP, ROCHIS | \n", + "614718 | \n", + "15q15.1 | \n", + "?Roifman-Chitayat syndrome, digenic | \n", + "613328 | \n", + "3 | \n", + "2 | \n", + "
603 | \n", + "?Roifman-Chitayat syndrome, digenic, 613328 (3) | \n", + "PIK3CD, APDS, IMD14A, IMD14B, ROCHIS | \n", + "602839 | \n", + "1p36.22 | \n", + "?Roifman-Chitayat syndrome, digenic | \n", + "613328 | \n", + "3 | \n", + "2 | \n", + "
1205 | \n", + "Bartter syndrome, type 4b, digenic, 613090 (3) | \n", + "CLCNKA | \n", + "602024 | \n", + "1p36.13 | \n", + "Bartter syndrome, type 4b, digenic | \n", + "613090 | \n", + "3 | \n", + "2 | \n", + "
1206 | \n", + "Bartter syndrome, type 4b, digenic, 613090 (3) | \n", + "CLCNKB | \n", + "602023 | \n", + "1p36.13 | \n", + "Bartter syndrome, type 4b, digenic | \n", + "613090 | \n", + "3 | \n", + "2 | \n", + "
3570 | \n", + "Hyperbilirubinemia, Rotor type, digenic, 237450 (3) | \n", + "SLCO1B1, LST1, OATP2, OATPC, OATP1B1, HBLRR | \n", + "604843 | \n", + "12p12.1 | \n", + "Hyperbilirubinemia, Rotor type, digenic | \n", + "237450 | \n", + "3 | \n", + "2 | \n", + "
3571 | \n", + "Hyperbilirubinemia, Rotor type, digenic, 237450 (3) | \n", + "SLCO1B3, OATP8, OATP1B3, SLC21A8, HBLRR | \n", + "605495 | \n", + "12p12.2 | \n", + "Hyperbilirubinemia, Rotor type, digenic | \n", + "237450 | \n", + "3 | \n", + "2 | \n", + "
\n", + " | Phenotype | \n", + "Gene/Locus And Other Related Symbols | \n", + "MIM Number | \n", + "Cyto Location | \n", + "p_label | \n", + "p_mim | \n", + "p_mapping_key | \n", + "p_mim_count | \n", + "
---|---|---|---|---|---|---|---|---|
0 | \n", + "2,4-dienoyl-CoA reductase deficiency, 616034 (3) | \n", + "NADK2, C5orf33, DECRD | \n", + "615787 | \n", + "5p13.2 | \n", + "2,4-dienoyl-CoA reductase deficiency | \n", + "616034 | \n", + "3 | \n", + "1 | \n", + "
1 | \n", + "2-methylbutyrylglycinuria, 610006 (3) | \n", + "ACADSB, SBCAD | \n", + "600301 | \n", + "10q26.13 | \n", + "2-methylbutyrylglycinuria | \n", + "610006 | \n", + "3 | \n", + "1 | \n", + "
2 | \n", + "3-M syndrome 1, 273750 (3) | \n", + "CUL7, 3M1 | \n", + "609577 | \n", + "6p21.1 | \n", + "3-M syndrome 1 | \n", + "273750 | \n", + "3 | \n", + "1 | \n", + "
3 | \n", + "3-M syndrome 2, 612921 (3) | \n", + "OBSL1, KIAA0657, 3M2 | \n", + "610991 | \n", + "2q35 | \n", + "3-M syndrome 2 | \n", + "612921 | \n", + "3 | \n", + "1 | \n", + "
4 | \n", + "3-M syndrome 3, 614205 (3) | \n", + "CCDC8, 3M3 | \n", + "614145 | \n", + "19q13.32 | \n", + "3-M syndrome 3 | \n", + "614205 | \n", + "3 | \n", + "1 | \n", + "
... | \n", + "... | \n", + "... | \n", + "... | \n", + "... | \n", + "... | \n", + "... | \n", + "... | \n", + "... | \n", + "
6396 | \n", + "{Warfarin sensitivity}, 301052 (3) | \n", + "F9, HEMB, THPH8 | \n", + "300746 | \n", + "Xq27.1 | \n", + "{Warfarin sensitivity} | \n", + "301052 | \n", + "3 | \n", + "1 | \n", + "
6397 | \n", + "{West nile virus, susceptibility to}, 610379 (3) | \n", + "CCR5, CMKBR5, CCCKR5, IDDM22 | \n", + "601373 | \n", + "3p21.31 | \n", + "{West nile virus, susceptibility to} | \n", + "610379 | \n", + "3 | \n", + "1 | \n", + "
6398 | \n", + "{Wilms tumor 6, susceptibility to}, 616806 (3) | \n", + "REST, NRSF, WT6, GINGF5, HGF5, DFNA27 | \n", + "600571 | \n", + "4q12 | \n", + "{Wilms tumor 6, susceptibility to} | \n", + "616806 | \n", + "3 | \n", + "1 | \n", + "
6399 | \n", + "{Wilms tumor susceptibility-5}, 601583 (3) | \n", + "POU6F2, WTSL, WT5 | \n", + "609062 | \n", + "7p14.1 | \n", + "{Wilms tumor susceptibility-5} | \n", + "601583 | \n", + "3 | \n", + "1 | \n", + "
6400 | \n", + "{Yao syndrome}, 617321 (3) | \n", + "NOD2, CARD15, IBD1, CD, YAOS, BLAUS | \n", + "605956 | \n", + "16q12.1 | \n", + "{Yao syndrome} | \n", + "617321 | \n", + "3 | \n", + "1 | \n", + "
6387 rows × 8 columns
\n", + "\n", + " | Phenotype | \n", + "Gene/Locus And Other Related Symbols | \n", + "MIM Number | \n", + "Cyto Location | \n", + "p_label | \n", + "p_mim | \n", + "p_mapping_key | \n", + "p_mim_count | \n", + "
---|---|---|---|---|---|---|---|---|
0 | \n", + "Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3) | \n", + "PRDX1, PRXI, PAGA, NKEFA | \n", + "176763 | \n", + "1p34.1 | \n", + "Methylmalonic aciduria and homocystinuria, cblC type, digenic | \n", + "277400 | \n", + "3 | \n", + "2 | \n", + "
1 | \n", + "Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3) | \n", + "MMACHC | \n", + "609831 | \n", + "1p34.1 | \n", + "Methylmalonic aciduria and homocystinuria, cblC type | \n", + "277400 | \n", + "3 | \n", + "2 | \n", + "
2 | \n", + "Insulin resistance, severe, digenic, 604367 (3) | \n", + "PPARG, PPARG1, PPARG2, CIMT1, GLM1 | \n", + "601487 | \n", + "3p25.2 | \n", + "Insulin resistance, severe, digenic | \n", + "604367 | \n", + "3 | \n", + "2 | \n", + "
3 | \n", + "Lipodystrophy, familial partial, type 3, 604367 (3) | \n", + "PPARG, PPARG1, PPARG2, CIMT1, GLM1 | \n", + "601487 | \n", + "3p25.2 | \n", + "Lipodystrophy, familial partial, type 3 | \n", + "604367 | \n", + "3 | \n", + "2 | \n", + "
4 | \n", + "Microphthalmia, isolated, with coloboma 6, 613703 (3) | \n", + "GDF3, KFS3, MCOPCB6, MCOP7 | \n", + "606522 | \n", + "12p13.31 | \n", + "Microphthalmia, isolated, with coloboma 6 | \n", + "613703 | \n", + "3 | \n", + "2 | \n", + "
5 | \n", + "Microphthalmia with coloboma 6, digenic, 613703 (3) | \n", + "GDF6, MCOP4, KFS1, MCOPCB6, LCA17, SYNS4 | \n", + "601147 | \n", + "8q22.1 | \n", + "Microphthalmia with coloboma 6, digenic | \n", + "613703 | \n", + "3 | \n", + "2 | \n", + "
6 | \n", + "[Bombay phenotype], 616754 (3) | \n", + "FUT1, H, HH | \n", + "211100 | \n", + "19q13.33 | \n", + "[Bombay phenotype] | \n", + "616754 | \n", + "3 | \n", + "2 | \n", + "
7 | \n", + "[Bombay phenotype, digenic], 616754 (3) | \n", + "FUT2, SE, B12QTL1 | \n", + "182100 | \n", + "19q13.33 | \n", + "[Bombay phenotype, digenic] | \n", + "616754 | \n", + "3 | \n", + "2 | \n", + "
8 | \n", + "Cardiomyopathy, familial hypertrophic, 192600 (3) | \n", + "CAV3, LQT9, MPDT, RMD2 | \n", + "601253 | \n", + "3p25.3 | \n", + "Cardiomyopathy, familial hypertrophic | \n", + "192600 | \n", + "3 | \n", + "3 | \n", + "
9 | \n", + "Cardiomyopathy, hypertrophic, 1, 192600 (3) | \n", + "MYH7, CMH1, MPD1, CMD1S, CMYO7A, CMYO7B | \n", + "160760 | \n", + "14q11.2 | \n", + "Cardiomyopathy, hypertrophic, 1 | \n", + "192600 | \n", + "3 | \n", + "3 | \n", + "
10 | \n", + "Cardiomyopathy, hypertrophic, 1, digenic, 192600 (3) | \n", + "MYLK2, MLCK | \n", + "606566 | \n", + "20q11.21 | \n", + "Cardiomyopathy, hypertrophic, 1, digenic | \n", + "192600 | \n", + "3 | \n", + "3 | \n", + "
11 | \n", + "Deafness, digenic, GJB2/GJB3, 220290 (3) | \n", + "GJB3, CX31, DFNA2B, EKVP1 | \n", + "603324 | \n", + "1p34.3 | \n", + "Deafness, digenic, GJB2/GJB3 | \n", + "220290 | \n", + "3 | \n", + "3 | \n", + "
12 | \n", + "Deafness, digenic GJB2/GJB6, 220290 (3) | \n", + "GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2 | \n", + "604418 | \n", + "13q12.11 | \n", + "Deafness, digenic GJB2/GJB6 | \n", + "220290 | \n", + "3 | \n", + "3 | \n", + "
13 | \n", + "Deafness, autosomal recessive 1A, 220290 (3) | \n", + "GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID, BAPS | \n", + "121011 | \n", + "13q12.11 | \n", + "Deafness, autosomal recessive 1A | \n", + "220290 | \n", + "3 | \n", + "3 | \n", + "
14 | \n", + "Deafness, autosomal recessive 4, with enlarged vestibular aqueduct, 600791 (3) | \n", + "SLC26A4, PDS, DFNB4, EVA, TDH2B | \n", + "605646 | \n", + "7q22.3 | \n", + "Deafness, autosomal recessive 4, with enlarged vestibular aqueduct | \n", + "600791 | \n", + "3 | \n", + "3 | \n", + "
15 | \n", + "Enlarged vestibular aqueduct, digenic, 600791 (3) | \n", + "KCNJ10, SESAME | \n", + "602208 | \n", + "1q23.2 | \n", + "Enlarged vestibular aqueduct, digenic | \n", + "600791 | \n", + "3 | \n", + "3 | \n", + "
16 | \n", + "Enlarged vestibular aqueduct, 600791 (3) | \n", + "FOXI1, FKHL10, FREAC6 | \n", + "601093 | \n", + "5q35.1 | \n", + "Enlarged vestibular aqueduct | \n", + "600791 | \n", + "3 | \n", + "3 | \n", + "
17 | \n", + "Usher syndrome, type 1D/F digenic, 601067 (3) | \n", + "PCDH15, DFNB23, USH1F | \n", + "605514 | \n", + "10q21.1 | \n", + "Usher syndrome, type 1D/F digenic | \n", + "601067 | \n", + "3 | \n", + "3 | \n", + "
18 | \n", + "Usher syndrome, type 1D/F digenic, 601067 (3) | \n", + "CDH23, USH1D, DFNB12, PITA5 | \n", + "605516 | \n", + "10q22.1 | \n", + "Usher syndrome, type 1D/F digenic | \n", + "601067 | \n", + "3 | \n", + "3 | \n", + "
19 | \n", + "Usher syndrome, type 1D, 601067 (3) | \n", + "CDH23, USH1D, DFNB12, PITA5 | \n", + "605516 | \n", + "10q22.1 | \n", + "Usher syndrome, type 1D | \n", + "601067 | \n", + "3 | \n", + "3 | \n", + "
20 | \n", + "Usher syndrome, type IIC, GPR98/PDZD7 digenic, 605472 (3) | \n", + "PDZD7, DFNB57 | \n", + "612971 | \n", + "10q24.31 | \n", + "Usher syndrome, type IIC, GPR98/PDZD7 digenic | \n", + "605472 | \n", + "3 | \n", + "3 | \n", + "
21 | \n", + "Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3) | \n", + "ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C | \n", + "602851 | \n", + "5q14.3 | \n", + "Usher syndrome, type 2C, GPR98/PDZD7 digenic | \n", + "605472 | \n", + "3 | \n", + "3 | \n", + "
22 | \n", + "Usher syndrome, type 2C, 605472 (3) | \n", + "ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C | \n", + "602851 | \n", + "5q14.3 | \n", + "Usher syndrome, type 2C | \n", + "605472 | \n", + "3 | \n", + "3 | \n", + "
23 | \n", + "Retinitis pigmentosa 7, digenic form, 608133 (3) | \n", + "ROM1, ROSP1, RP7 | \n", + "180721 | \n", + "11q12.3 | \n", + "Retinitis pigmentosa 7, digenic form | \n", + "608133 | \n", + "3 | \n", + "3 | \n", + "
24 | \n", + "Retinitis pigmentosa 7 and digenic form, 608133 (3) | \n", + "PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1 | \n", + "179605 | \n", + "6p21.1 | \n", + "Retinitis pigmentosa 7 and digenic form | \n", + "608133 | \n", + "3 | \n", + "3 | \n", + "
25 | \n", + "Leber congenital amaurosis 18, 608133 (3) | \n", + "PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1 | \n", + "179605 | \n", + "6p21.1 | \n", + "Leber congenital amaurosis 18 | \n", + "608133 | \n", + "3 | \n", + "3 | \n", + "
26 | \n", + "{Diabetes mellitus, noninsulin-dependent}, 125853 (3) | \n", + "SLC2A2, GLUT2 | \n", + "138160 | \n", + "3q26.2 | \n", + "{Diabetes mellitus, noninsulin-dependent} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
27 | \n", + "{Diabetes mellitus, type 2, susceptibility to}, 125853 (3) | \n", + "KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13, PNDM2 | \n", + "600937 | \n", + "11p15.1 | \n", + "{Diabetes mellitus, type 2, susceptibility to} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
28 | \n", + "{Diabetes mellitus, type 2, susceptibility to}, 125853 (3) | \n", + "MTNR1B | \n", + "600804 | \n", + "11q14.3 | \n", + "{Diabetes mellitus, type 2, susceptibility to} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
29 | \n", + "{Diabetes mellitus, type 2, susceptibility to}, 125853 (3) | \n", + "TCF7L2, TCF4 | \n", + "602228 | \n", + "10q25.2-q25.3 | \n", + "{Diabetes mellitus, type 2, susceptibility to} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
30 | \n", + "{Diabetes mellitus, type II, susceptibility to}, 125853 (3) | \n", + "PDX1, IPF1, MODY4, PAGEN1 | \n", + "600733 | \n", + "13q12.2 | \n", + "{Diabetes mellitus, type II, susceptibility to} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
31 | \n", + "Insulin resistance, severe, digenic, 125853 (3) | \n", + "PPP1R3A, PPP1R3 | \n", + "600917 | \n", + "7q31.1 | \n", + "Insulin resistance, severe, digenic | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
32 | \n", + "{Diabetes, type 2}, 125853 (3) | \n", + "PPARG, PPARG1, PPARG2, CIMT1, GLM1 | \n", + "601487 | \n", + "3p25.2 | \n", + "{Diabetes, type 2} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
33 | \n", + "{Hypertension, insulin resistance-related, susceptibility to}, 125853 (3) | \n", + "RETN, RSTN, FIZZ3 | \n", + "605565 | \n", + "19p13.2 | \n", + "{Hypertension, insulin resistance-related, susceptibility to} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
34 | \n", + "{Insulin resistance, susceptibility to}, 125853 (3) | \n", + "PTPN1, PTP1B | \n", + "176885 | \n", + "20q13.13 | \n", + "{Insulin resistance, susceptibility to} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
35 | \n", + "{Type 2 diabetes mellitus, susceptibility to}, 125853 (3) | \n", + "GPD2 | \n", + "138430 | \n", + "2q24.1 | \n", + "{Type 2 diabetes mellitus, susceptibility to} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
36 | \n", + "{Type 2 diabetes mellitus, susceptibility to}, 125853 (3) | \n", + "HMGA1, HMGIY | \n", + "600701 | \n", + "6p21.31 | \n", + "{Type 2 diabetes mellitus, susceptibility to} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
37 | \n", + "{Type 2 diabetes mellitus, susceptibility to}, 125853 (3) | \n", + "IRS1 | \n", + "147545 | \n", + "2q36.3 | \n", + "{Type 2 diabetes mellitus, susceptibility to} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
38 | \n", + "{Diabetes mellitus, noninsulin-dependent}, 125853 (3) | \n", + "MAPK8IP1, IB1 | \n", + "604641 | \n", + "11p11.2 | \n", + "{Diabetes mellitus, noninsulin-dependent} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
39 | \n", + "{Diabetes mellitus, noninsulin-dependent}, 125853 (3) | \n", + "LIPC, HL, LIPH, HDLCQ12 | \n", + "151670 | \n", + "15q21.3 | \n", + "{Diabetes mellitus, noninsulin-dependent} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
40 | \n", + "{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3) | \n", + "RETN, RSTN, FIZZ3 | \n", + "605565 | \n", + "19p13.2 | \n", + "{Diabetes mellitus, noninsulin-dependent, susceptibility to} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
41 | \n", + "{Diabetes mellitus, noninsulin-dependent}, 125853 (3) | \n", + "HNF4A, TCF14, MODY1, FRTS4 | \n", + "600281 | \n", + "20q13.12 | \n", + "{Diabetes mellitus, noninsulin-dependent} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
42 | \n", + "{Diabetes mellitus, noninsulin-dependent}, 125853 (2) | \n", + "NIDDM4 | \n", + "608036 | \n", + "5q34-q35.2 | \n", + "{Diabetes mellitus, noninsulin-dependent} | \n", + "125853 | \n", + "2 | \n", + "30 | \n", + "
43 | \n", + "{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3) | \n", + "SLC30A8, ZNT8 | \n", + "611145 | \n", + "8q24.11 | \n", + "{Diabetes mellitus, noninsulin-dependent, susceptibility to} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
44 | \n", + "{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3) | \n", + "IGF2BP2, IMP2 | \n", + "608289 | \n", + "3q27.2 | \n", + "{Diabetes mellitus, noninsulin-dependent, susceptibility to} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
45 | \n", + "{Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3) | \n", + "WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41 | \n", + "606201 | \n", + "4p16.1 | \n", + "{Diabetes mellitus, noninsulin-dependent, association with} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
46 | \n", + "{Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3) | \n", + "HNF1A, TCF1, MODY3, IDDM20 | \n", + "142410 | \n", + "12q24.31 | \n", + "{Diabetes mellitus, noninsulin-dependent, 2} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
47 | \n", + "{Diabetes mellitus, non-insulin-dependent, susceptibility to}, 125853 (3) | \n", + "ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED | \n", + "173335 | \n", + "6q23.2 | \n", + "{Diabetes mellitus, non-insulin-dependent, susceptibility to} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
48 | \n", + "{Type 2 diabetes mellitus, susceptibility to}, 125853 (3) | \n", + "NEUROD1, T2D | \n", + "601724 | \n", + "2q31.3 | \n", + "{Type 2 diabetes mellitus, susceptibility to} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
49 | \n", + "Diabetes mellitus, noninsulin-dependent, 125853 (3) | \n", + "ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2, PNDM3 | \n", + "600509 | \n", + "11p15.1 | \n", + "Diabetes mellitus, noninsulin-dependent | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
50 | \n", + "Type 2 diabetes mellitus, 125853 (3) | \n", + "HNF1B, TCF2, HNF2, RCAD, T2D, ADTKD3 | \n", + "189907 | \n", + "17q12 | \n", + "Type 2 diabetes mellitus | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
51 | \n", + "Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3) | \n", + "GCK, HHF3, PNDM1 | \n", + "138079 | \n", + "7p13 | \n", + "Diabetes mellitus, noninsulin-dependent, late onset | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
52 | \n", + "Diabetes mellitus, type 2, 125853 (3) | \n", + "PAX4, MODY9, KPD | \n", + "167413 | \n", + "7q32.1 | \n", + "Diabetes mellitus, type 2 | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
53 | \n", + "Diabetes mellitus, type II, 125853 (3) | \n", + "AKT2, HIHGHH | \n", + "164731 | \n", + "19q13.2 | \n", + "Diabetes mellitus, type II | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
54 | \n", + "{Diabetes mellitus, noninsulin-dependent}, 125853 (3) | \n", + "IRS2 | \n", + "600797 | \n", + "13q34 | \n", + "{Diabetes mellitus, noninsulin-dependent} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
55 | \n", + "{Type 2 diabetes mellitus}, 125853 (3) | \n", + "IL6, IFNB2, BSF2, HSF, HGF | \n", + "147620 | \n", + "7p15.3 | \n", + "{Type 2 diabetes mellitus} | \n", + "125853 | \n", + "3 | \n", + "30 | \n", + "
\n", + " | Phenotype | \n", + "Gene/Locus And Other Related Symbols | \n", + "MIM Number | \n", + "Cyto Location | \n", + "p_label | \n", + "p_mim | \n", + "p_mapping_key | \n", + "p_mim_count | \n", + "
---|---|---|---|---|---|---|---|---|
0 | \n", + "2,4-dienoyl-CoA reductase deficiency, 616034 (3) | \n", + "NADK2, C5orf33, DECRD | \n", + "615787 | \n", + "5p13.2 | \n", + "2,4-dienoyl-CoA reductase deficiency | \n", + "616034 | \n", + "3 | \n", + "1 | \n", + "
1 | \n", + "2-methylbutyrylglycinuria, 610006 (3) | \n", + "ACADSB, SBCAD | \n", + "600301 | \n", + "10q26.13 | \n", + "2-methylbutyrylglycinuria | \n", + "610006 | \n", + "3 | \n", + "1 | \n", + "
2 | \n", + "3-M syndrome 1, 273750 (3) | \n", + "CUL7, 3M1 | \n", + "609577 | \n", + "6p21.1 | \n", + "3-M syndrome 1 | \n", + "273750 | \n", + "3 | \n", + "1 | \n", + "
3 | \n", + "3-M syndrome 2, 612921 (3) | \n", + "OBSL1, KIAA0657, 3M2 | \n", + "610991 | \n", + "2q35 | \n", + "3-M syndrome 2 | \n", + "612921 | \n", + "3 | \n", + "1 | \n", + "
4 | \n", + "3-M syndrome 3, 614205 (3) | \n", + "CCDC8, 3M3 | \n", + "614145 | \n", + "19q13.32 | \n", + "3-M syndrome 3 | \n", + "614205 | \n", + "3 | \n", + "1 | \n", + "
\n", + " | Prefix | \n", + "MIM Number | \n", + "Preferred Title; symbol | \n", + "Alternative Title(s); symbol(s) | \n", + "Included Title(s); symbols | \n", + "
---|---|---|---|---|---|
0 | \n", + "NaN | \n", + "100050 | \n", + "AARSKOG SYNDROME, AUTOSOMAL DOMINANT | \n", + "NaN | \n", + "NaN | \n", + "
1 | \n", + "Percent | \n", + "100070 | \n", + "AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 1; AAA1 | \n", + "ANEURYSM, ABDOMINAL AORTIC; AAA;; ABDOMINAL AORTIC ANEURYSM | \n", + "NaN | \n", + "
2 | \n", + "Number Sign | \n", + "100100 | \n", + "PRUNE BELLY SYNDROME; PBS | \n", + "ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY AND CRYPTORCHIDISM;; EAGLE-BARRETT SYNDROME; EGBRS | \n", + "NaN | \n", + "
3 | \n", + "NaN | \n", + "100200 | \n", + "ABDUCENS PALSY | \n", + "NaN | \n", + "NaN | \n", + "
4 | \n", + "Number Sign | \n", + "100300 | \n", + "ADAMS-OLIVER SYNDROME 1; AOS1 | \n", + "AOS;; ABSENCE DEFECT OF LIMBS, SCALP, AND SKULL;; CONGENITAL SCALP DEFECTS WITH DISTAL LIMB REDUCTION ANOMALIES;; APLASIA CUTIS CONGENITA WITH TERMINAL TRANSVERSE LIMB DEFECTS | \n", + "APLASIA CUTIS CONGENITA, CONGENITAL HEART DEFECT, AND FRONTONASAL CYSTS, INCLUDED | \n", + "
\n", + " | Phenotype | \n", + "Gene/Locus And Other Related Symbols | \n", + "MIM Number | \n", + "Cyto Location | \n", + "p_label | \n", + "p_mim | \n", + "p_mapping_key | \n", + "p_mim_count | \n", + "
---|---|---|---|---|---|---|---|---|
0 | \n", + "2,4-dienoyl-CoA reductase deficiency, 616034 (3) | \n", + "NADK2, C5orf33, DECRD | \n", + "615787 | \n", + "5p13.2 | \n", + "2,4-dienoyl-CoA reductase deficiency | \n", + "616034 | \n", + "3 | \n", + "1 | \n", + "
1 | \n", + "2-methylbutyrylglycinuria, 610006 (3) | \n", + "ACADSB, SBCAD | \n", + "600301 | \n", + "10q26.13 | \n", + "2-methylbutyrylglycinuria | \n", + "610006 | \n", + "3 | \n", + "1 | \n", + "
2 | \n", + "3-M syndrome 1, 273750 (3) | \n", + "CUL7, 3M1 | \n", + "609577 | \n", + "6p21.1 | \n", + "3-M syndrome 1 | \n", + "273750 | \n", + "3 | \n", + "1 | \n", + "
3 | \n", + "3-M syndrome 2, 612921 (3) | \n", + "OBSL1, KIAA0657, 3M2 | \n", + "610991 | \n", + "2q35 | \n", + "3-M syndrome 2 | \n", + "612921 | \n", + "3 | \n", + "1 | \n", + "
4 | \n", + "3-M syndrome 3, 614205 (3) | \n", + "CCDC8, 3M3 | \n", + "614145 | \n", + "19q13.32 | \n", + "3-M syndrome 3 | \n", + "614205 | \n", + "3 | \n", + "1 | \n", + "
5 | \n", + "3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3) | \n", + "MCCC1, MCCA | \n", + "609010 | \n", + "3q27.1 | \n", + "3-Methylcrotonyl-CoA carboxylase 1 deficiency | \n", + "210200 | \n", + "3 | \n", + "1 | \n", + "
6 | \n", + "3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3) | \n", + "MCCC2, MCCB | \n", + "609014 | \n", + "5q13.2 | \n", + "3-Methylcrotonyl-CoA carboxylase 2 deficiency | \n", + "210210 | \n", + "3 | \n", + "1 | \n", + "
7 | \n", + "3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3) | \n", + "HADHSC, SCHAD, HHF4 | \n", + "601609 | \n", + "4q25 | \n", + "3-hydroxyacyl-CoA dehydrogenase deficiency | \n", + "231530 | \n", + "3 | \n", + "1 | \n", + "
8 | \n", + "3-hydroxyisobutryl-CoA hydrolase deficiency, 250620 (3) | \n", + "HIBCH | \n", + "610690 | \n", + "2q32.2 | \n", + "3-hydroxyisobutryl-CoA hydrolase deficiency | \n", + "250620 | \n", + "3 | \n", + "1 | \n", + "
9 | \n", + "3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome, 614739 (3) | \n", + "SERAC1, MEGDEL | \n", + "614725 | \n", + "6q25.3 | \n", + "3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome | \n", + "614739 | \n", + "3 | \n", + "1 | \n", + "
\n", + " | Phenotype | \n", + "Gene/Locus And Other Related Symbols | \n", + "MIM Number | \n", + "Cyto Location | \n", + "
---|---|---|---|---|
0 | \n", + "17,20-lyase deficiency, isolated, 202110 (3) | \n", + "CYP17A1, CYP17, P450C17 | \n", + "609300 | \n", + "10q24.32 | \n", + "
1 | \n", + "17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3) | \n", + "CYP17A1, CYP17, P450C17 | \n", + "609300 | \n", + "10q24.32 | \n", + "
2 | \n", + "2,4-dienoyl-CoA reductase deficiency, 616034 (3) | \n", + "NADK2, C5orf33, DECRD | \n", + "615787 | \n", + "5p13.2 | \n", + "
3 | \n", + "2-methylbutyrylglycinuria, 610006 (3) | \n", + "ACADSB, SBCAD | \n", + "600301 | \n", + "10q26.13 | \n", + "
4 | \n", + "3-M syndrome 1, 273750 (3) | \n", + "CUL7, 3M1 | \n", + "609577 | \n", + "6p21.1 | \n", + "
\n", + " | Phenotype | \n", + "Gene/Locus And Other Related Symbols | \n", + "MIM Number | \n", + "Cyto Location | \n", + "p_label | \n", + "p_mim | \n", + "p_mapping_key | \n", + "
---|---|---|---|---|---|---|---|
0 | \n", + "17,20-lyase deficiency, isolated, 202110 (3) | \n", + "CYP17A1, CYP17, P450C17 | \n", + "609300 | \n", + "10q24.32 | \n", + "17,20-lyase deficiency, isolated | \n", + "202110 | \n", + "3 | \n", + "
1 | \n", + "17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3) | \n", + "CYP17A1, CYP17, P450C17 | \n", + "609300 | \n", + "10q24.32 | \n", + "17-alpha-hydroxylase/17,20-lyase deficiency | \n", + "202110 | \n", + "3 | \n", + "
2 | \n", + "2,4-dienoyl-CoA reductase deficiency, 616034 (3) | \n", + "NADK2, C5orf33, DECRD | \n", + "615787 | \n", + "5p13.2 | \n", + "2,4-dienoyl-CoA reductase deficiency | \n", + "616034 | \n", + "3 | \n", + "
3 | \n", + "2-methylbutyrylglycinuria, 610006 (3) | \n", + "ACADSB, SBCAD | \n", + "600301 | \n", + "10q26.13 | \n", + "2-methylbutyrylglycinuria | \n", + "610006 | \n", + "3 | \n", + "
4 | \n", + "3-M syndrome 1, 273750 (3) | \n", + "CUL7, 3M1 | \n", + "609577 | \n", + "6p21.1 | \n", + "3-M syndrome 1 | \n", + "273750 | \n", + "3 | \n", + "
\n", + " | Phenotype | \n", + "Gene/Locus And Other Related Symbols | \n", + "MIM Number | \n", + "Cyto Location | \n", + "p_label | \n", + "p_mim | \n", + "p_mapping_key | \n", + "
---|---|---|---|---|---|---|---|
2 | \n", + "2,4-dienoyl-CoA reductase deficiency, 616034 (3) | \n", + "NADK2, C5orf33, DECRD | \n", + "615787 | \n", + "5p13.2 | \n", + "2,4-dienoyl-CoA reductase deficiency | \n", + "616034 | \n", + "3 | \n", + "
3 | \n", + "2-methylbutyrylglycinuria, 610006 (3) | \n", + "ACADSB, SBCAD | \n", + "600301 | \n", + "10q26.13 | \n", + "2-methylbutyrylglycinuria | \n", + "610006 | \n", + "3 | \n", + "
4 | \n", + "3-M syndrome 1, 273750 (3) | \n", + "CUL7, 3M1 | \n", + "609577 | \n", + "6p21.1 | \n", + "3-M syndrome 1 | \n", + "273750 | \n", + "3 | \n", + "
5 | \n", + "3-M syndrome 2, 612921 (3) | \n", + "OBSL1, KIAA0657, 3M2 | \n", + "610991 | \n", + "2q35 | \n", + "3-M syndrome 2 | \n", + "612921 | \n", + "3 | \n", + "
6 | \n", + "3-M syndrome 3, 614205 (3) | \n", + "CCDC8, 3M3 | \n", + "614145 | \n", + "19q13.32 | \n", + "3-M syndrome 3 | \n", + "614205 | \n", + "3 | \n", + "
\n", + " | Phenotype | \n", + "Gene/Locus And Other Related Symbols | \n", + "MIM Number | \n", + "Cyto Location | \n", + "p_label | \n", + "p_mim | \n", + "p_mapping_key | \n", + "
---|---|---|---|---|---|---|---|
2 | \n", + "2,4-dienoyl-CoA reductase deficiency, 616034 (3) | \n", + "NADK2, C5orf33, DECRD | \n", + "615787 | \n", + "5p13.2 | \n", + "2,4-dienoyl-CoA reductase deficiency | \n", + "616034 | \n", + "3 | \n", + "
3 | \n", + "2-methylbutyrylglycinuria, 610006 (3) | \n", + "ACADSB, SBCAD | \n", + "600301 | \n", + "10q26.13 | \n", + "2-methylbutyrylglycinuria | \n", + "610006 | \n", + "3 | \n", + "
4 | \n", + "3-M syndrome 1, 273750 (3) | \n", + "CUL7, 3M1 | \n", + "609577 | \n", + "6p21.1 | \n", + "3-M syndrome 1 | \n", + "273750 | \n", + "3 | \n", + "
5 | \n", + "3-M syndrome 2, 612921 (3) | \n", + "OBSL1, KIAA0657, 3M2 | \n", + "610991 | \n", + "2q35 | \n", + "3-M syndrome 2 | \n", + "612921 | \n", + "3 | \n", + "
6 | \n", + "3-M syndrome 3, 614205 (3) | \n", + "CCDC8, 3M3 | \n", + "614145 | \n", + "19q13.32 | \n", + "3-M syndrome 3 | \n", + "614205 | \n", + "3 | \n", + "
\n", + " | Phenotype | \n", + "Gene/Locus And Other Related Symbols | \n", + "MIM Number | \n", + "Cyto Location | \n", + "p_label | \n", + "p_mim | \n", + "p_mapping_key | \n", + "
---|---|---|---|---|---|---|---|
2 | \n", + "2,4-dienoyl-CoA reductase deficiency, 616034 (3) | \n", + "NADK2, C5orf33, DECRD | \n", + "615787 | \n", + "5p13.2 | \n", + "2,4-dienoyl-CoA reductase deficiency | \n", + "616034 | \n", + "3 | \n", + "
3 | \n", + "2-methylbutyrylglycinuria, 610006 (3) | \n", + "ACADSB, SBCAD | \n", + "600301 | \n", + "10q26.13 | \n", + "2-methylbutyrylglycinuria | \n", + "610006 | \n", + "3 | \n", + "
4 | \n", + "3-M syndrome 1, 273750 (3) | \n", + "CUL7, 3M1 | \n", + "609577 | \n", + "6p21.1 | \n", + "3-M syndrome 1 | \n", + "273750 | \n", + "3 | \n", + "
5 | \n", + "3-M syndrome 2, 612921 (3) | \n", + "OBSL1, KIAA0657, 3M2 | \n", + "610991 | \n", + "2q35 | \n", + "3-M syndrome 2 | \n", + "612921 | \n", + "3 | \n", + "
6 | \n", + "3-M syndrome 3, 614205 (3) | \n", + "CCDC8, 3M3 | \n", + "614145 | \n", + "19q13.32 | \n", + "3-M syndrome 3 | \n", + "614205 | \n", + "3 | \n", + "
\n", + " | Prefix | \n", + "MIM Number | \n", + "Preferred Title; symbol | \n", + "Alternative Title(s); symbol(s) | \n", + "Included Title(s); symbols | \n", + "
---|---|---|---|---|---|
0 | \n", + "NaN | \n", + "100050 | \n", + "AARSKOG SYNDROME, AUTOSOMAL DOMINANT | \n", + "NaN | \n", + "NaN | \n", + "
1 | \n", + "Percent | \n", + "100070 | \n", + "AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 1; AAA1 | \n", + "ANEURYSM, ABDOMINAL AORTIC; AAA;; ABDOMINAL AORTIC ANEURYSM | \n", + "NaN | \n", + "
2 | \n", + "Number Sign | \n", + "100100 | \n", + "PRUNE BELLY SYNDROME; PBS | \n", + "ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY AND CRYPTORCHIDISM;; EAGLE-BARRETT SYNDROME; EGBRS | \n", + "NaN | \n", + "
3 | \n", + "NaN | \n", + "100200 | \n", + "ABDUCENS PALSY | \n", + "NaN | \n", + "NaN | \n", + "
4 | \n", + "Number Sign | \n", + "100300 | \n", + "ADAMS-OLIVER SYNDROME 1; AOS1 | \n", + "AOS;; ABSENCE DEFECT OF LIMBS, SCALP, AND SKULL;; CONGENITAL SCALP DEFECTS WITH DISTAL LIMB REDUCTION ANOMALIES;; APLASIA CUTIS CONGENITA WITH TERMINAL TRANSVERSE LIMB DEFECTS | \n", + "APLASIA CUTIS CONGENITA, CONGENITAL HEART DEFECT, AND FRONTONASAL CYSTS, INCLUDED | \n", + "
\n", + " | Phenotype | \n", + "Gene/Locus And Other Related Symbols | \n", + "MIM Number_x | \n", + "Cyto Location | \n", + "p_label | \n", + "p_mim | \n", + "p_mapping_key | \n", + "Prefix | \n", + "MIM Number_y | \n", + "Preferred Title; symbol | \n", + "Alternative Title(s); symbol(s) | \n", + "Included Title(s); symbols | \n", + "
---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | \n", + "2,4-dienoyl-CoA reductase deficiency, 616034 (3) | \n", + "NADK2, C5orf33, DECRD | \n", + "615787 | \n", + "5p13.2 | \n", + "2,4-dienoyl-CoA reductase deficiency | \n", + "616034 | \n", + "3 | \n", + "Number Sign | \n", + "616034 | \n", + "2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD | \n", + "NaN | \n", + "NaN | \n", + "
1 | \n", + "2-methylbutyrylglycinuria, 610006 (3) | \n", + "ACADSB, SBCAD | \n", + "600301 | \n", + "10q26.13 | \n", + "2-methylbutyrylglycinuria | \n", + "610006 | \n", + "3 | \n", + "Number Sign | \n", + "610006 | \n", + "2-METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY | \n", + "2-METHYLBUTYRYL GLYCINURIA;; SHORT/BRANCHED-CHAIN ACYL-CoA DEHYDROGENASE DEFICIENCY; SBCADD | \n", + "NaN | \n", + "
2 | \n", + "3-M syndrome 1, 273750 (3) | \n", + "CUL7, 3M1 | \n", + "609577 | \n", + "6p21.1 | \n", + "3-M syndrome 1 | \n", + "273750 | \n", + "3 | \n", + "Number Sign | \n", + "273750 | \n", + "THREE M SYNDROME 1; 3M1 | \n", + "3M SYNDROME;; LE MERRER SYNDROME;; DOLICHOSPONDYLIC DYSPLASIA;; GLOOMY FACE SYNDROME | \n", + "YAKUT SHORT STATURE SYNDROME, INCLUDED | \n", + "
3 | \n", + "3-M syndrome 2, 612921 (3) | \n", + "OBSL1, KIAA0657, 3M2 | \n", + "610991 | \n", + "2q35 | \n", + "3-M syndrome 2 | \n", + "612921 | \n", + "3 | \n", + "Number Sign | \n", + "612921 | \n", + "THREE M SYNDROME 2; 3M2 | \n", + "3M SYNDROME 2 | \n", + "NaN | \n", + "
4 | \n", + "3-M syndrome 3, 614205 (3) | \n", + "CCDC8, 3M3 | \n", + "614145 | \n", + "19q13.32 | \n", + "3-M syndrome 3 | \n", + "614205 | \n", + "3 | \n", + "Number Sign | \n", + "614205 | \n", + "THREE M SYNDROME 3; 3M3 | \n", + "3M SYNDROME 3 | \n", + "NaN | \n", + "
\n", + " | Phenotype | \n", + "Gene/Locus And Other Related Symbols | \n", + "Gene MIM | \n", + "Cyto Location | \n", + "p_label | \n", + "p_mim | \n", + "p_mapping_key | \n", + "Prefix | \n", + "Phenotype MIM | \n", + "
---|---|---|---|---|---|---|---|---|---|
0 | \n", + "2,4-dienoyl-CoA reductase deficiency, 616034 (3) | \n", + "NADK2, C5orf33, DECRD | \n", + "615787 | \n", + "5p13.2 | \n", + "2,4-dienoyl-CoA reductase deficiency | \n", + "616034 | \n", + "3 | \n", + "Number Sign | \n", + "616034 | \n", + "
1 | \n", + "2-methylbutyrylglycinuria, 610006 (3) | \n", + "ACADSB, SBCAD | \n", + "600301 | \n", + "10q26.13 | \n", + "2-methylbutyrylglycinuria | \n", + "610006 | \n", + "3 | \n", + "Number Sign | \n", + "610006 | \n", + "
2 | \n", + "3-M syndrome 1, 273750 (3) | \n", + "CUL7, 3M1 | \n", + "609577 | \n", + "6p21.1 | \n", + "3-M syndrome 1 | \n", + "273750 | \n", + "3 | \n", + "Number Sign | \n", + "273750 | \n", + "
3 | \n", + "3-M syndrome 2, 612921 (3) | \n", + "OBSL1, KIAA0657, 3M2 | \n", + "610991 | \n", + "2q35 | \n", + "3-M syndrome 2 | \n", + "612921 | \n", + "3 | \n", + "Number Sign | \n", + "612921 | \n", + "
4 | \n", + "3-M syndrome 3, 614205 (3) | \n", + "CCDC8, 3M3 | \n", + "614145 | \n", + "19q13.32 | \n", + "3-M syndrome 3 | \n", + "614205 | \n", + "3 | \n", + "Number Sign | \n", + "614205 | \n", + "
\n", + " | Phenotype | \n", + "Gene/Locus And Other Related Symbols | \n", + "Gene MIM | \n", + "Cyto Location | \n", + "p_label | \n", + "p_mim | \n", + "p_mapping_key | \n", + "Prefix | \n", + "Phenotype MIM | \n", + "
---|---|---|---|---|---|---|---|---|---|
1151 | \n", + "Congenital smooth muscle hamartoma with or without hemihypertrophy, somatic mosaic, 620479 (3) | \n", + "ACTB, BRWS1, BNS, CSMH, DDS1, BRWS1, THC8 | \n", + "102630 | \n", + "7p22.1 | \n", + "Congenital smooth muscle hamartoma with or without hemihypertrophy, somatic mosaic | \n", + "620479 | \n", + "3 | \n", + "Asterisk | \n", + "620479 | \n", + "
2901 | \n", + "Leukemia, acute promyelocytic, somatic, 102578 (3) | \n", + "STAT5B, GHISID2 | \n", + "604260 | \n", + "17q21.2 | \n", + "Leukemia, acute promyelocytic, somatic | \n", + "102578 | \n", + "3 | \n", + "Asterisk | \n", + "102578 | \n", + "
\n", + " | Phenotype | \n", + "Gene/Locus And Other Related Symbols | \n", + "Gene MIM | \n", + "Cyto Location | \n", + "p_label | \n", + "p_mim | \n", + "p_mapping_key | \n", + "Prefix | \n", + "Phenotype MIM | \n", + "
---|---|---|---|---|---|---|---|---|---|
0 | \n", + "2,4-dienoyl-CoA reductase deficiency, 616034 (3) | \n", + "NADK2, C5orf33, DECRD | \n", + "615787 | \n", + "5p13.2 | \n", + "2,4-dienoyl-CoA reductase deficiency | \n", + "616034 | \n", + "3 | \n", + "Number Sign | \n", + "616034 | \n", + "
1 | \n", + "2-methylbutyrylglycinuria, 610006 (3) | \n", + "ACADSB, SBCAD | \n", + "600301 | \n", + "10q26.13 | \n", + "2-methylbutyrylglycinuria | \n", + "610006 | \n", + "3 | \n", + "Number Sign | \n", + "610006 | \n", + "
2 | \n", + "3-M syndrome 1, 273750 (3) | \n", + "CUL7, 3M1 | \n", + "609577 | \n", + "6p21.1 | \n", + "3-M syndrome 1 | \n", + "273750 | \n", + "3 | \n", + "Number Sign | \n", + "273750 | \n", + "
3 | \n", + "3-M syndrome 2, 612921 (3) | \n", + "OBSL1, KIAA0657, 3M2 | \n", + "610991 | \n", + "2q35 | \n", + "3-M syndrome 2 | \n", + "612921 | \n", + "3 | \n", + "Number Sign | \n", + "612921 | \n", + "
4 | \n", + "3-M syndrome 3, 614205 (3) | \n", + "CCDC8, 3M3 | \n", + "614145 | \n", + "19q13.32 | \n", + "3-M syndrome 3 | \n", + "614205 | \n", + "3 | \n", + "Number Sign | \n", + "614205 | \n", + "